13F Data
13F filer · CIK 310158

Merck & Co., Inc.

RAHWAY, NJ · filing since Q4 2024 · last filing Aug 7, 2026
Reported value
$526.4M
+$177.0M vs prior
Positions
13
New / sold out
3 / 4
Added / reduced
0 / 0
Turnover
5.8%
buys $25.6M · sells $33.3M
Top-10 weight
99.8%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewENTRADA THERAPEUTICS INC+1,739,768–+$12.8M
NewSUTRO BIOPHARMA INC+272,351–+$9.0M
NewEVAXION BIOTECH A/S+1,214,126–+$3.8M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outENTRADA THERAPEUTICS INC-1,739,768-100.0%$-22.0M
Sold outSUTRO BIOPHARMA INC-272,351-100.0%$-6.8M
Sold outEVAXION BIOTECH A/S-1,214,126-100.0%$-4.5M
Sold outCARISMA THERAPEUTICS INC-1,473,240-100.0%$-47.9K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2024: $258.0MQ1 2025: $164.3MQ2 2025: $215.6MQ3 2025: $228.0MQ4 2025: $276.3MQ1 2026: $349.4MQ2 2026: $526.4M
Q4 2024Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1PERSONALIS INCCOM14,044,943$188.2M35.75%
2MODERNA INCCOM2,308,190$161.6M30.71%
3KYMERA THERAPEUTICS INCCOM772,165$88.5M16.82%
4AKTIS ONCOLOGY INCCOM952,844$30.7M5.83%
5EIKON THERAPEUTICS INCCOM1,666,666$21.7M4.13%
6ENTRADA THERAPEUTICS INCCOM1,739,768$12.8M2.43%
7SUTRO BIOPHARMA INCCOM272,351$9.0M1.72%
8ALECTOR INCCOM3,545,719$7.1M1.35%
9EVAXION BIOTECH A/SSPONSORED ADS1,214,126$3.8M0.71%
10VIRIDIAN THERAPEUTICS INCCOM93,414$1.7M0.33%
3 more rows. Subscribe for $29/month to see every row, download the data and use the API.